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Abstract Recent studies have revealed an unexpected
synergism between two seemingly unrelated protein fami-
lies: CCN matricellular proteins and the tumor necrosis
factor (TNF) family of cytokines. CCN proteins are
dynamically expressed at sites of injury repair and
inflammation, where TNF cytokines are also expressed.
Although TNFα is an apoptotic inducer in some cancer
cells, it activates NFκB to promote survival and prolifera-
tion in normal cells, and its cytotoxicity requires inhibition
of de novo protein synthesis or NFκB signaling. The
presence of CCN1, CCN2, or CCN3 overrides this
requirement and unmasks the apoptotic potential of TNFα,
thus converting TNFα from a proliferation-promoting
protein into an apoptotic inducer. These CCN proteins also
enhance the cytotoxicity of other TNF cytokines, including
LTα, FasL, and TRAIL. Mechanistically, CCNs function
through integrin α6β1 and the heparan sulfate proteoglycan
(HSPG) syndecan-4 to induce reactive oxygen species
(ROS) accumulation, which is essential for apoptotic
synergism. Mutant CCN1 proteins defective for binding
α6β1-HSPGs are unable to induce ROS or apoptotic
synergism with TNF cytokines. Further, knockin mice that
express an α6β1-HSPG-binding defective CCN1 are
blunted in TNFα- and Fas-mediated apoptosis, indicating
that CCN1 is a physiologic regulator of these processes.
These findings implicate CCN proteins as contextual
regulators of the inflammatory response by dictating or
enhancing the cytotoxicity of TNFα and related cytokines.
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Introduction
Apoptosis is an evolutionarily conserved process in
multicellular organisms for eliminating unwanted or dam-
aged cells, and is critical for normal development and tissue
homeostasis. Environmental factors, such as UV irradiation
or oxidative stress, can cause or increase susceptibility to
apopotsis. A number of endogenously produced proteins,
notably members of the tumor necrosis factor (TNF) family
of cytokines including TNFα, lymphotoxin-α (LTα), Fas
ligand (FasL), and TNF-related apoptosis-inducing ligand
(TRAIL), can induce apoptosis by binding to specific
receptors on the surface of target cells. The ensuing
signaling events, characterized by the activation of the
caspase family of intracellular proteinases, lead to cell
shrinkage and DNA fragmentation. The resulting cellular
debris is engulfed and removed by macrophages and other
surrounding cells.
The extracellular matrix (ECM) has long been recog-
nized as a critical survival factor. Cell adhesion to ECM
proteins such as fibronectin through integrin receptors
activates cytoprotective signaling pathways involving
PI3K, JNK, and ERK to suppress apoptosis (Almeida et
al. 2000). When deprived of proper interaction with the
ECM or if integrins are unligated or improperly ligated,
normal cells undergo a form of apoptosis called anoikis
(Cheresh and Stupack 2008; Chiarugi and Giannoni 2008).
Contrary to the prevailing view that the ECM serves a pro-
survival role, recent studies have revealed that certain ECM
molecules can promote or induce apoptosis (Marastoni et
al. 2008). For example, the CCN family of proteins can
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promote apoptosis through integrin-dependent activation of
p53 even as they support cell adhesion and induce adhesive
signaling (Todorovic et al. 2005), whereas EMILIN2 can
induce apoptosis by binding to the death receptors DR-4
and DR-5 (Mongiat et al. 2007). Surprisingly, CCN
proteins can also enable or promote the cytotoxicity of the
TNF family cytokines both in vitro and in vivo, thus
altering the matrix microenvironment to dictate or support
TNF cytokine-dependent cell death (Fig. 1). This review
focuses on the novel signaling crosstalk that underpins the
unexpected synergism between these two seemingly unre-
lated protein families.
Apoptotic synergism between members of the CCN
and TNF families
The CCN family is comprised of six structurally conserved,
ECM-associated signaling proteins in vertebrates (Leask
and Abraham 2006; Holbourn et al. 2008; Chen and Lau
2009). The first three members described, Cyr61 (cysteine
rich 61, CCN1), connective tissue growth factor (CTGF,
CCN2), and nephroblastoma overexpressed (Nov, CCN3),
provided the acronym for the CCN family. CCNs regulate
diverse aspects of cell behavior including cell adhesion,
migration, proliferation, survival, and differentiation with-
out being integral structural components of the matrix, and
as such they fit the characteristics of “matricellular”
proteins (Bornstein 1995; Lau and Lam 1999). Like many
ECM proteins, they function through direct interaction with
integrin receptors and cell surface heparan sulfate pro-
teoglyans (HSPGs) to mediate many of their activities
(Kireeva et al. 1998; Chen et al. 2000).
The TNF superfamily includes at least 19 cytokines that
play critical roles in regulating the development and
function of the immune system (Locksley et al. 2001;
Aggarwal 2003). A subset of this family, such as TNFα,
LTα, FasL, and TRAIL, can also induce cell death. TNF
cytokine-dependent cell death may play important roles in
the removal of damaged or potentially cancerous cells as
part of immune surveillance, but can also contribute to the
etiology of a variety of diseases if it occurs excessively.
TNFα was initially found to induce necrotic and apoptotic
death in certain cancer cells; however, subsequent studies
showed that TNFα alone promotes survival of normal cells
in culture and its cytotoxicity is only revealed when de
novo protein synthesis or NFκB signaling is blocked
(Varfolomeev and Ashkenazi 2004; Muppidi et al. 2004).
TNFα activates the transcription factor NFκB, which
induces the expression of a large number of proteins critical
for cell survival and inflammation. Since TNFα can
activate both survival and apoptotic signaling, its cytotox-
icity is highly contextual and dependent on the presence of
sensitizing contributors such as viral infection or IFN-γ that
perturbs NFκB signaling or protein synthesis (Varfolomeev
and Ashkenazi 2004; Muppidi et al. 2004). LTα binds the
same receptors as TNFα and is thought to act similarly. By
contrast, FasL and TRAIL are weak inducers of NFκB and
can induce cell death on their own; however, their
cytotoxicity is also regulated by other environmental
factors.
In adults, CCNs are highly expressed at sites of tissue
damage and inflammation where TNF family cytokines are
also expressed in many instances, providing the opportunity
for CCNs and TNF cytokines to interact. Recently we
showed that CCN1 and CCN2, either in a soluble form or
as adhesion substrates, enable TNFα to induce apoptosis
without perturbation of protein synthesis or NFκB signal-
ing, and enhance the cytotoxic effects of FasL and TRAIL
(Chen et al. 2007; Juric et al. 2009; Franzen et al. 2009).
Indeed, the interactions between the CCN and TNF families
extend even further: CCN1, CCN2, and CCN3, can each
unmask the cytotoxicity of TNFα and LTα, and promote
the apoptotic activity of FasL and TRAIL in normal human
fibroblasts, resulting in rapid apoptosis within 4–6 h
(Fig. 2). Although CCNs do not trigger cell death on their
own under these conditions, they induced apoptosis in
~25% of cells in combination with TNFα or LTα, and
enhanced the apoptotic efficacy of FasL and TRAIL by at
least 2-fold (Fig. 2). These observations are remarkable,
since TNFα normally promotes the proliferation of fibro-





Fig. 1 CCN1 tips the balance in TNFα-regulated life and death
decisions. TNFα is a potent activator of NFκB, a master transcription
factor that induces the expression of genes that promote cell
proliferation and survival, and suppress apoptosis. Blockade of de
novo protein synthesis or NFκB signaling unleashes the apoptotic
potential of TNFα, allowing TNFα-induced apoptosis to proceed. The
presence of CCN1 overrides the effects of NFkB by increasing the
cellular accumulation of ROS, leading to apoptosis without inhibiting
protein synthesis or NFκB activity
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cytotoxic (Battegay et al. 1995). Thus, the presence of
CCNs turns TNFα from being a proliferation-enhancing
agent into a cytotoxic factor. These activities appear unique
to members of the CCN family and were not found in other
ECM proteins tested, such as collagen, fibronectin, laminin,
and vitronectin.
NFκB suppresses the cytotoxicity of TNFα
When TNFα engages its cell surface receptor TNFR1, the
death domain in the receptor cytoplasmic tail recruits the
adaptor protein TRADD, which further recruits RIP and
TRAF2 that participate in the activation of NFκB and JNK
(Fig. 3). The RIP, TRAF2, and TRADD complex (complex
I) subsequently dissociates from the receptor and recruits
FADD and procaspase-8/-10 into a secondary complex
(complex II) in which activation of procaspase-8/-10 occurs
(Muppidi et al. 2004; Bertazza and Mocellin 2008).
Whereas caspases-8/-10 can directly activate caspase-3 by
proteolysis to trigger apoptosis, in some cell types caspase-
8 cleaves and activates the BH3-only protein Bid, leading
to cytochrome c release from the mitochondria and
amplification of the apoptotic signal. Cytoplasmic cyto-
chrome c complexes with Apaf-1 and activates caspase-9,
which further activates caspase-3 to trigger apoptosis.
In normal cells, the pro-survival protein c-FLIP com-
petes with procaspases-8/-10 for binding to the RIP/
TRADD/TRAF2/FADD complex, thus preventing caspase
activation. TNFα-activated NFκB induces the transcription
and synthesis of c-FLIP, adding to the existing cellular pool
of c-FLIP and creating a further obstacle to caspase
activation. The function of c-FLIP is opposed by the
stress-induced kinase JNK, which promotes apoptosis by
phosphorylating the ubiquitin ligase ITCH and thereby
targeting c-FLIP for degradation (Chang et al. 2006). If
JNK activation is robust and prolonged, c-FLIP is obliter-
ated and TNFα-induced apoptosis can occur. However,
under normal conditions TNFα-activated JNK is rapidly
inactivated by phosphatases. Reactive oxygen species
(ROS), which are generated as microbicides in phagocytic
cells, or as second messengers mediating diverse cellular
functions in non-phagocytic cells, are important regulators
of JNK because they can inactivate phosphatases by
oxidation of the critical cysteine residue in the enzyme


















Fig. 2 Apoptotic synergism between the CCN and TNF protein
families. Normal human skin fibroblasts were serum-starved overnight
before being treated for 6 h at 37°C with serum-free media containing
purified recombinant CCN1, CCN2, or CCN3 proteins (5 μg/ml
each), with or without TNFα (10 ng/ml), LTα (10 ng/ml), FasL
(50 ng/ml), or TRAIL (20 ng/ml) as indicated. Apoptotic cells were
scored as described (Chen et al. 2007)
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Fig. 3 TNFα induced
signaling. TNFα is capable of
inducing both pro-survival and
pro-apoptotic signaling through
its receptor TNFR1. Formation
of complex 1 leads to activation
of NFκB and its downstream
effectors, while complex II can
trigger apoptosis through activa-
tion of the caspase cascade. The
apoptotic pathway is blocked by
c-FLIP, which is targeted for
degradation by the ubiquitin
ligase ITCH and apoptosis can
proceed if JNK activation is
sustained (Chang et al. 2006).
Signaling molecules in green
provide survival functions, while
those in red contribute to apo-
ptosis. Those in yellow promote
apoptosis only when superacti-
vated under certain contexts
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cellular ROS can inactivate phosphatases and allow TNFα-
induced JNK activation to remain sustained, thereby
leading to c-FLIP degradation and apoptosis (Kamata et
al. 2005). Although TNFα itself induces ROS production,
TNFα-induced ROS are quickly downregulated by NFκB,
which activates the synthesis of anti-oxidant proteins such
as Mn-superoxide dismutase and ferritin heavy chain (Pham
et al. 2004). In addition, NFκB can induce the expression of
phosphatases to restrain JNK activation. Therefore, NFκB
counteracts the TNFα-induced apoptotic pathway by
inducing the synthesis of c-FLIP, phosphatases, and
antioxidant proteins, all of which conspire to block
TNFα-induced apoptosis.
CCNs enables TNFα cytotoxicity and promotes FasL
activity through ROS
Although inhibition of de novo protein synthesis or NFκB
signaling is the most common way to enable TNFα
induction of apoptosis in normal cells, CCNs do not perturb
either process. In addition, CCN1 and TNFα induces ~2-
fold more apoptosis and with a much faster kinetics (4–6 h
vs. 24 h) compared to apoptosis induction by cyclohexi-
mide and TNFα, further suggesting that CCN1 works
through a distinct mechanism (Chen et al. 2007). Indeed,
CCNs act through inducing the accumulation of a high
level of ROS to override the anti-apoptotic effects of NFκB,
thus unmasking the cytotoxicity of TNFα (Fig. 4). Both
CCN1 and CCN2 induce ROS production in fibroblasts,
and neutralization of ROS with chemical scavengers or
inhibiting cellular mechanism of ROS production annihi-
lates their apoptotic synergism with TNFα and FasL (Chen
et al. 2007; Juric et al. 2009). TNFα alone induces a
transient JNK activation and a low level of ROS that is
quickly dampened by NFκB-induced anti-oxidant proteins.
Despite NFκB actions, the combination of CCN1 and
TNFα induces a sufficient amount of ROS to trigger a
robust and biphasic activation of JNK (Chen et al. 2007).
Upon CCN1/TNFα treatment, JNK activation occurs
within 15 min. but transiently declines between 1 and 3 h
after stimulation, most likely due to NFκB-induced synthe-
sis of new phosphatases. Eventually CCN1-induced ROS
may inhibit the newly synthesized phosphatases and a
second phase of JNK activation occurs between 4 and 6 h
after stimulation, concomitant with cell death. This second
phase of JNK activation, which is not seen in TNFα
stimulation alone, is essential for CCN1/TNFα-induced
apoptosis.
In CCN1/FasL synergism, CCN1 induces ROS to
hyperactivate p38 MAPK, leading to the activation and
mitochondrial localization of Bax and consequent cyto-
chrome c release (Juric et al. 2009). Other reports also show
that p38 can phosphorylate and inhibit the pro-survival
activity of members of the Bcl-family, thereby promoting
Bax/Bak activation and mitochondrial cytochrome c release
(Torcia et al. 2001; Gomez-Lazaro et al. 2007). However,
ROS does not seem to play an important role in CCN1
synergism with TRAIL in PC-3 prostate cancer cells,
suggesting cell-type specific differences in the mechanism
of apoptotic synergism (Franzen et al. 2009). Interestingly,
CCN1 action is a double edge sword in prostate carcinoma
cells, since it promotes the proliferation of prostate cells but
also enhances the cytotoxicity of TRAIL. Thus, cancer cells
may overexpress CCN proteins to promote their prolifera-
tion, although this also puts them at risk of higher
susceptibility to TRAIL-mediated immune surveillance.
Mechanisms of ROS induction by CCN1
Integrin-mediated cell adhesion to ECM proteins generates
ROS, which is required for the adhesion process (Chiarugi
et al. 2003). Integrin signaling is known to activate small
GTPases such as RAC and RHO, leading to disassembly
and repolymerization of F-actin, formation of lamellipodia,
and clustering of ligand-bound integrins into focal com-
plexes. RAC can also regulate ROS generation through
multiple mechanisms, including 5-lipoxygenase (LOX)
(Chiarugi et al. 2003), specific isoforms of NADPH
oxidases (NOX)(Chiarugi et al. 2003), and the mitochon-
dria (Werner and Werb 2002)(Fig. 4). Whereas LOX
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Fig. 4 Signaling crosstalk between CCN1 and TNFα or FasL. In
fibroblasts, CCN1 acts through binding integrins α6β1, αvβ5, and the
cell surface HSPG syndecan-4, leading to generation of ROS by
several mechanisms that include the activities of 5-LOX, nSMases,
and the mitochondria. A high level of ROS enhances and maintains
the activation of the cellular kinases JNK, which targets c-FLIP for
degradation and allows TNFα to activate caspases-8 and -10 and
induce apoptosis, and p38 MAPK, which promotes FasL-induced Bax
activation and cytochrome c release
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catalyzes the metabolism of arachidonic acid to leuko-
trienes, NOX generates free superoxide from molecular
oxygen and is the predominant source of ROS in
phagocytic cells. Integrin-mediated fibroblast adhesion to
CCN1 and CCN2 activates RAC1 (Chen et al. 2001),
which induces ROS generation through 5-LOX and
mitochondria for apoptotic synergism with TNFα (Chen
et al. 2007). CCN1 interaction with integrins αvβ5, α6β1,
and the HSPG syndecan-4 is required for this process, and
this requirement of multiple receptors may help specify the
target cells for elimination. Although TNFα itself induces
ROS via NOX-dependent mechanisms to mediate apoptosis
and necrosis (Chen et al. 2007; Kim et al. 2007;
Yazdanpanah et al. 2009), inhibition of NOX has no effect
on CCN1/TNFα synergism, showing a remarkable specificity
of ROS in these distinct pathways.
A recent study shows that CCN1 can activate neutral
sphingomyelinase 1 (nSMase1) (Juric et al. 2009), which
generates the lipid second messenger ceramide that can
increase ROS through several mechanisms (Won and Singh
2006). In CCN1/FasL synergism, the activation of
nSMase1 plays a critical role in the generation of ROS that
triggers the hyperactivation of p38, leading to enhanced
Bax activation and cytochrome c release. The discovery
that matrix proteins can activate nSMase1 is without
precedent, and the mechanism of nSMase1 activation
through integrin signaling is currently unknown.
In vivo evidence of the synergism
Since Ccn1- and Ccn2-null mice are embryonic and
perinatal lethal, respectively, they cannot be used to address
the roles of CCNs in TNFα or Fas-mediated apoptosis in
vivo. To circumvent this problem, knockin mice were
created in which the Ccn1 genomic locus was replaced by
an allele encoding DM, a CCN1 mutant that is disrupted in
two α6β1-HSPG binding sites located in the carboxy-
terminal domain (Chen et al. 2000, 2007). The resultant
CCN1-DM protein is still active in promoting αv integrin-
mediated cellular activities (Leu et al. 2004), but is unable
to induce ROS accumulation or synergize with TNFα or
FasL to promote fibroblast apoptosis (Chen et al. 2007;
Juric et al. 2009). Unlike Ccn1-null mice, Ccn1dm/dm mice
are viable, fertile, and show no obvious morphological or
behavioral defects. When injected subcutaneously with a
small bolus of soluble TNFα to induce dermal apoptosis,
these mutant mice showed >60% reduction in apoptotic
cells compared to wild-type mice, consistent with CCN1/
TNFα synergism in vivo (Chen et al. 2007).
To study TNF cytokine-mediated cytotoxicity in vivo,
Ccn1dm/dm mice were tested in three different models of
hepatotoxin-induced apoptosis: intravenous delivery of
concanavalin A (ConA), intravenous injection of an
agontistic monoclonal antibody that activates Fas (clone
Jo2), and intragastric administration of alcohol. ConA
induces robust TNFα synthesis in macrophages and T cells
and leads to massive TNFα-dependent hepatocyte apopto-
sis, which is completely abrogated by neutralizing anti-
bodies against TNFα or by genetic ablation of TNFR1 and
TNFR2 (Trautwein et al. 1998; Wolf et al. 2001). To
examine Fas-mediated apoptosis, the monoclonal antibody
Jo2 recognizes and activates the Fas receptor to induce Fas-
mediated apoptosis, a process that is annihilated by genetic
disruption of Fas, demonstrating the specificity for Fas
(Ogasawara et al. 1993). In addition, ethanol gavage in
mice mimics binge drinking and results in FasL-induced
hepatocyte apoptosis that is ablated by neutralizing anti-
bodies against FasL (Zhou et al. 2001). In all three
experimental models, Ccn1dm/dm mice consistently show
>60% reduction in hepatocyte apoptosis compared to wild-
type mice (Fig. 5) (Juric et al. 2009; Chen et al. 2007).
These results show that CCN1 is a physiological regulator
of TNFα and Fas-mediated apoptosis in vivo, and suggest
an important role for CCN1 in the pathogenesis of toxin-
induced hepatitis. However, these findings do not exclude
the participation of other factors such as IFNγ, which may
regulate TNF cytokine cytotoxicity in certain contexts.
Fig. 5 CCN1 is critical for TNFα and Fas-mediated apoptosis in
vivo. Ccn1dm/dm knockin mice express the CCN1 mutant DM, which
is disrupted in the binding sites for α6β1 and HSPGs and is therefore
unable to induce ROS or apoptosis. TNFα-induced apoptosis was
tested by either direct subcutaneous injection of TNFα, or by
treatment with ConA, which induces TNFα production from macro-
phages (Chen et al. 2007). Fas-mediated apoptosis was tested by tail-
vein injection of the agonistic mAb, Jo2, or by a gavage of ethanol. In
each scenario, apoptosis is reduced by 60–70% in Ccn1dm/dm mice
compared to wild type mice, indicating that CCN1 is critical for
optimal TNFα and Fas-mediated apoptosis in vivo
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Future questions
The results summarized above indicate that CCNmatricellular
proteins are contextual regulators of several TNF family
cytokines, dictating or promoting their cytotoxicity. However,
many other questions still remain. Since cell adhesion to other
ECM proteins also generates ROS, what might be the
underlying mechanism that sets CCNs apart in being able to
synergize with TNFs? Do the remaining members of the CCN
and TNF families interact, and do CCNs regulate TNF family
cytokine functions other than apoptosis? Beyond fibroblasts
and hepatocytes, which cell types are susceptible to CCN/
TNF synergism?
Since CCNs and TNFα are coexpressed at sites of
inflammation, it is tempting to speculate that CCNs may
help to terminate the inflammatory responses initiated by
TNFα by unmasking its apoptotic function. Inasmuch as
chronic inflammation and elevated TNFα levels contribute
to the morbidity of many diseases, CCN/TNF interaction
may play an important role in the loss of functional cells
during disease progression. For example, in acute and
chronic diseases of the liver, such as hepatitis, fibrosis, and
fulminant liver failure caused by viral infection, alcohol
abuse, and hepatotoxin exposure, elevated levels of TNFα
are observed and in some cases TNFα-dependent apoptosis
correlate with disease severity (Muto et al. 1988; Czaja et
al. 1989; Bird et al. 1990; Gonzalez-Amaro et al. 1994;
Blazka et al. 1995; Shibata et al. 2008). Beyond hepatic
pathology, other contexts in which CCN/TNF-mediated
apoptosis may play a role include placental inflammation
and cardiomyopathy, since CCN expression and marked
TNFα-dependent apoptosis occur concurrently (Haider and
Knofler 2009; Yaoita and Maruyama 2008). The possibility
that CCN/TNF synergism may play important roles in the
pathogenesis of various diseases mentioned above is
intriguing and clearly merits further investigation.
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